Back to top
more

Cross Country Healthcare (CCRN)

(Delayed Data from NSDQ)

$12.53 USD

12.53
403,480

-0.57 (-4.35%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $12.56 +0.03 (0.24%) 7:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 20% (196 out of 246)

Industry: Staffing Firms

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Charles River (CRAI) Rides on Business Model, Global Presence

by Zacks Equity Research

Solid international network, business diversification and an excellent professional team boost Charles River (CRAI).

Zacks Equity Research

The Zacks Analyst Blog Highlights Cross Country Healthcare, Kforce, RCM Technologies and KornFerry International

by Zacks Equity Research

Cross Country Healthcare, Kforce, RCM Technologies and KornFerry International are part of Zacks top Analyst Blog.

Zacks Equity Research

Reasons Why You Should Invest in H&R Block (HRB) Stock Now

by Zacks Equity Research

H&R Block's (HRB) digitalization of its business can be one of the primary drivers of its performance post the pandemic..

Ritujay Ghosh headshot

4 Staffing Stocks to Watch on Solid Job Additions to Economy

by Ritujay Ghosh

The United States has been adding a record number of jobs, helping staffing stocks Cross Country Healthcare, Inc. (CCRN), Kforce Inc. (KFRC), RCM Technologies, Inc. (RCMT) and KornFerry International (KFY).

Zacks Equity Research

Here's Why You Should Retain Omnicom (OMC) in Portfolio Now

by Zacks Equity Research

Omnicom (OMC) rides on solid investor-friendly steps and organic growth initiatives.

Zacks Equity Research

Reasons to Retain Insperity (NSP) Stock in Your Portfolio

by Zacks Equity Research

Insperity (NSP) puts consistent efforts to reward shareholders through share repurchases and dividends. Increasing expenses remain a concern.

Zacks Equity Research

5 Reasons to Add Gartner (IT) Stock to Your Portfolio Now

by Zacks Equity Research

Gartner's (IT) high-quality, timely, thought-provoking and comprehensive analysis offering helps it counter growing competition.

Zacks Equity Research

Here's Why Investors Should Buy ABM Industries (ABM) Now

by Zacks Equity Research

Strategic acquisitions and investor-friendly steps boost ABM Industries (ABM).

Zacks Equity Research

Reasons to Retain ICF International (ICFI) in Your Portfolio

by Zacks Equity Research

ICF International, Inc. (ICFI) is seeing solid growth in its service revenues driven by strength in IT modernization and digitization, disaster management and public health services.

Zacks Equity Research

The Zacks Analyst Blog Highlights Kforce, Tyler Technologies, IBEX, Cross Country Healthcare, and RCM Technologies.

by Zacks Equity Research

Kforce, Tyler Technologies, IBEX, Cross Country Healthcare, and RCM Technologies are part of Zacks top Analyst Blog.

Zacks Equity Research

Accenture (ACN) to Gain From Advocate Buyout: Here's How

by Zacks Equity Research

The latest deal is expected to help Accenture (ACN) expand its technology business management capabilities.

Nalak Das headshot

5 Business Services Stocks to Buy on Solid Job Data for May

by Nalak Das

We have narrowed our search to five business services stocks that have solid potential for the rest of 2022. These are: KFRC, IBEX, TYL, CCRN and RCMT.

Zacks Equity Research

Does Cross Country (CCRN) Have the Potential to Rally 89% as Wall Street Analysts Expect?

by Zacks Equity Research

The mean of analysts' price targets for Cross Country (CCRN) points to an 89.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

Accenture (ACN) to Gain From Greenfish Buyout: Here's How

by Zacks Equity Research

The latest deal is expected to strengthen Accenture's (ACN) sustainability services across Europe.

Zacks Equity Research

Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio

by Zacks Equity Research

Stericycle (SRCL) has strong customer relationships in the form of long-term contracts ranging from three to five years.

Zacks Equity Research

Accenture (ACN) to Benefit From ARZ Acquisition: Here's How

by Zacks Equity Research

The latest deal is expected to help Accenture (ACN) broaden its banking platform-as-a-service capabilities across Europe.

Zacks Equity Research

Reasons to Retain Waste Management (WM) Stock in Your Portfolio

by Zacks Equity Research

Waste Management (WM) continues to execute core operating initiatives targeting focused differentiation and continuous improvement.

Zacks Equity Research

6 Reasons to Buy Automatic Data Processing (ADP) Stock Now

by Zacks Equity Research

Acquisition strategy and initiatives to streamline and expand its business should drive Automatic Data Processing's (ADP) prospects.

Zacks Equity Research

Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now

by Zacks Equity Research

IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.

Zacks Equity Research

6 Reasons to Add Avis Budget (CAR) Stock to Your Portfolio Now

by Zacks Equity Research

Acquisitions, technology enhancement and fleet expansion bode well for Avis Budget (CAR).

Zacks Equity Research

Reasons to Add Paychex (PAYX) Stock to Your Portfolio Now

by Zacks Equity Research

Paychex's (PAYX) solid business model, diversified products and services, and strategic acquisitions boost top-line growth.

Zacks Equity Research

Green Dot (GDOT) Rides on Prolonged Partnership With Walmart

by Zacks Equity Research

Time-honored relationship with Walmart boosts Green Dot (GDOT).

Zacks Equity Research

Rollins' (ROL) Acquisitions Aid, Rising Expenses Ail

by Zacks Equity Research

Rollins (ROL) is a steady dividend payer with a balanced approach to organic and inorganic growth.

Zacks Equity Research

Reasons to Retain Rollins (ROL) Stock in Your Portfolio

by Zacks Equity Research

Rollins (ROL) is currently benefiting from strength in all of its business lines.

Zacks Equity Research

Reasons to Bet on Cross Country Healthcare (CCRN) Stock

by Zacks Equity Research

Cross Country Healthcare (CCRN) is currently benefiting from its investments in headcount and technology.